| Outlook: Roles of FSH and LH during the follicular phase: insight into natural cycle IVF. | |
| | |
MedLine Citation:
|
PMID: 18028740 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A mounting interest in natural cycle IVF has challenged the medical community to better understand the mechanisms controlling the follicular phase and ovulation in particular, in an effort to optimize this procedure and its outcome. For practical reasons, the advancement of the follicular phase in the menstrual cycle is commonly timed according to the onset of last menses. However, this precludes knowing when the follicular phase truly begins and hampers the possibility of optimizing timing of late follicular-phase events, notably, the triggering of ovulation. Clinicians, therefore, use surrogate markers of follicular maturation, such as oestrogen production and follicular size. Because it is impossible to identify the low-amplitude intercycle basal FSH signal, efforts have reverted toward controlling when it takes place, either with exogenous oestrogen or with oral contraceptives. In the late follicular phase, the occurrence of LH surge results from a balance between the opposite effects of rising oestrogen concentrations, which favour the LH surge, and the opposing effects mediated by the gonadotrophin surge-attenuating factor, a peptide of ovarian origin. This review looks into the mechanisms that control these two hinges of the follicular phase, the basal FSH signal and LH surge, in the context of optimizing natural cycle IVF. |
| | |
Authors:
|
Dominique de Ziegler; Timothee Fraisse; Gabriel de Candolle; Nicolas Vulliemoz; Marina Bellavia; Silvia Colamaria |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Reproductive biomedicine online Volume: 15 ISSN: 1472-6483 ISO Abbreviation: Reprod. Biomed. Online Publication Date: 2007 Nov |
Date Detail:
|
Created Date: 2007-11-21 Completed Date: 2008-01-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101122473 Medline TA: Reprod Biomed Online Country: England |
Other Details:
|
Languages: eng Pagination: 507-13 Citation Subset: IM |
Affiliation:
|
Joint Division of Reproductive Endocrinology and Infertility, University Hospitals of Geneva and Lausanne, 30 Bd de la Cluse, 1211 Geneva, Switzerland. ddeziegler@bluewin.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Contraceptives, Oral
/
therapeutic use Estrogens / physiology, therapeutic use Female Fertilization in Vitro / methods* Follicle Stimulating Hormone / physiology* Follicular Phase / physiology* Gonadal Hormones / physiology Humans Infertility, Female / drug therapy Luteinizing Hormone / physiology* Ovarian Follicle / physiology* Proteins / physiology |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptives, Oral; 0/Estrogens; 0/Gonadal Hormones; 0/Proteins; 0/attenuin; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.
Next Document: The effects of male age on sperm DNA damage in an infertile population.